Oncoheroes Biosciences is now at a crucial moment in its quest to find effective therapies for pediatric cancer patients, as they have the unprecedented opportunity to test Volasertib, one of its thre...
Read moreUNIQUE-CaixaImpulse platform has three state-of-the-art devices that are integrated into the VHIO’s core transversal technology platforms. For example, it has a Parsotix machine which is capable of ...
Read moreA European multicentre study shows that the BL-DetecTool is highly sensitive in detecting two families of enzymes associated with antibiotic resistance directly from clinical samples
Read moreEl consorcio formado por dos equipos del CSIC y el Instituto J Craig Venter de Estados Unidos recibe la ayuda en Biología y Biomedicina del Programa Fundamentos de la Fundación BBVA para abordar de ...
Read moreAn international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer after CAR T-cell therapy.
Read moreUn estudio liderado por el CSIC ayuda a detectar y analizar las oscilaciones rápidas, biomarcadores relacionados con la memoria, la epilepsia o el alzhéimer
Read moreEl convenio permite que las startups instaladas en LivingCells accedan de manera gratuita a los servicios de Madrid Impulsa Tech, entidad de enlace de la Innovación Tecnológica de la Comunidad de Ma...
Read moreAs Oncoheroes prepares to evaluate the efficacy of its lead compound, volasertib, across five pediatric cancer indications, including rhabdomyosarcoma, the Super Sam Foundation once again steps forwar...
Read more